A search of the Medicines and Healthcare Products Regulatory Agency (MHRA) website revealed no manufacturer Field Safety Notices or Medical Device Alerts for this device. No reports of adverse events ...

Cepheid announced it has received clearance from the Food and Drug Administration (FDA) to market Xpert Norovirus, an in vitro diagnostic test for identification and differentiation of Noroviruses ...

Cepheid has announced the European release of the Xpert™ MRSA (Methicillin-resistant Staphylococcus aureus) test for clinical diagnostic use on the GeneXpert ® System. The MRSA test was released as a ...

SUNNYVALE, Calif., May 29, 2019 /PRNewswire/ -- Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for testing throat and rectal specimens with its ...

Xpert CT/NG Test for Chlamydia and Gonorrhea Approved Cepheid announced that it has received clearance from the FDA to market Xpert CT/NG, an in vitro molecular diagnostic test for the detection and ...

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States Following initial clearance of Xpert TV for three types of female specimens in October of 2015, the latest ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Viral load assay will be made available at concessionary prices to public and non-for-profit providers. FIND (Foundation for Innovative New Diagnostics) has agreed to put $5 million into a ...

In an attempt to strengthen its foothold in the virology market, molecular diagnostics corporation Cepheid ( CPHD), together with the not-for-profit organization - Foundation for Innovative New ...

In the policy statement on the Xpert MTB/RIF test in 2011, the WHO recommended the use of the test as an initial diagnostic tool among children with suspected HIV associated TB or MDR TB based on ...